Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
The independent source for health policy research, polling, and news.
321 - 340 of 476 Results
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
The politics of COVID-19 are pretty polarized, but health experts across the ideological spectrum agree: The U.S. will need more robust testing before it鈥檚 safe to relax social-distancing requirements. Meanwhile, President Donald Trump, Congress and the nation鈥檚 governors continue to spar over who should be responsible for what. Kimberly Leonard of Business Insider, Tami Luhby of CNN and Anna Edney of Bloomberg News join KHN鈥檚 Julie Rovner to discuss this and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.
As efforts ramp up to collect blood plasma from the first survivors of COVID-19, families of critically ill patients are jockeying to obtain the still-unproven antibody treatment.
Josie and George Taylor of Everett, Washington, are two of the first people in the U.S. to recover from novel coronavirus infections after joining a clinical trial for the antiviral drug remdesivir.
States urgently need millions of tests, and the game changer they鈥檝e been waiting on falls well short of what is needed, according to government documents obtained by KHN.
Americans are worried about the novel coronavirus, so they are turning to the internet for solutions to stem their fears. Buyer, beware. It could be dangerous.
A common complaint about the testing process is the long turnaround time for results.
Nationwide, testing for coronavirus is ramping up. But the supply of specialty swabs needed to collect potential coronavirus specimens can鈥檛 keep up with demand, creating a bottleneck in testing capabilities. So two top manufacturers are working with U.S. and Italian governments to increase production.
Drs. Keith Jerome and Alex Greninger fast-tracked a test for the deadly new coronavirus weeks before it began spreading in the U.S. Their work has been key to detecting community transmission and ramping up the nation鈥檚 testing capacity.
A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug鈥檚 approval, many doctors are wary.
SmileDirectClub and similar startup companies say they provide these services at what can be thousands of dollars less than office-visit teeth straightening, but proof is lacking and patients can be left with no recourse if problems arise.
The impact of the Trump administration鈥檚 health policies is not as clear-cut as the president鈥檚 reelection campaign suggests.
A group of Democratic state attorneys general are betting the Supreme Court will take up the case and overturn a federal appeals court ruling in time for the 2020 elections. In other high-court news, most Republicans in Congress are asking the justices to use a Louisiana law to overturn the landmark abortion-rights ruling, Roe v. Wade. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN鈥檚 Julie Rovner to discuss this and more. Rovner also interviews NPR鈥檚 Richard Harris, who wrote the latest KHN-NPR 鈥淏ill of the Month鈥 feature.
As happens when the tech industry gets involved, hype surrounds the claims that artificial intelligence will help patients and even replace some doctors.
Because of a little-known federal exemption program, death data about heart devices sits in inaccessible FDA files that can take up to two years for the public to see under open-records laws.
A standard connector for feeding tubes was supposed to improve patient safety by preventing accidental misconnections to equipment used for IVs or other purposes. But critics say the design instead could keep patients from real food and inadvertently creates a host of new risks, including for vulnerable premature infants.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don鈥檛 have to.
The annual accounting of national health spending is out. And the 2018 health bill for the U.S. was $3.6 trillion, consuming nearly a fifth of the nation鈥檚 economy. Meanwhile, Congress is nearing the end of the year without having finished either its annual spending bills or several other high-priority health items. Kimberly Leonard of the Washington Examiner, Joanne Kenen of Politico and Mary Agnes Carey of Kaiser Health News join KHN鈥檚 Julie Rovner to discuss this and more. Also, Rovner interviews KHN鈥檚 Markian Hawryluk about the latest KHN-NPR 鈥淏ill of the Month.鈥
Millions of injuries and malfunctions once funneled into a hidden Food and Drug Administration database are now available.
漏 2026 KFF